FSCSX
Price
$19.57
Change
+$0.13 (+0.67%)
Updated
Jul 24 closing price
Net Assets
6.67B
FTCHX
Price
$72.11
Change
-$2.68 (-3.58%)
Updated
Jul 24 closing price
Net Assets
2.56B
Interact to see
Advertisement

FSCSX vs FTCHX

FSCSX vs FTCHX Comparison Chart in %
View a ticker or compare two or three
VS
FSCSX vs. FTCHX commentary
Jul 27, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSCSX is a Buy and FTCHX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSCSX has more cash in the bank: 6.67B vs. FTCHX (2.56B). FSCSX (0.00) and FTCHX (0.00) have matching dividends . FSCSX was incepted earlier than FTCHX: FSCSX (41 years) vs FTCHX (43 years). FTCHX (0.91) is less costly to investors than FSCSX (0.61). FTCHX is a more actively managed with annual turnover of: 159.00 vs. FSCSX (62.00). FSCSX has a lower initial minimum investment than FTCHX: FSCSX (0) vs FTCHX (1000). FTCHX annual gain was more profitable for investors over the last year : 8.71 vs. FSCSX (-32.70). FTCHX return over 5 years is better than : -6.22 vs. FSCSX (-38.03).
FSCSXFTCHXFSCSX / FTCHX
Total Expense Ratio0.610.9167%
Annual Report Gross Expense Ratio0.610.9167%
Fund Existence41 years43 years-
Gain YTD-22.43423.794-94%
Front LoadN/AN/A-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets6.67B2.56B261%
Annual Yield % from dividends0.000.00-
Returns for 1 year-32.708.71-375%
Returns for 3 years-25.9049.64-52%
Returns for 5 years-38.03-6.22612%
Returns for 10 years52.64101.9952%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NSRX3.120.03
+0.87%
Nasus Pharma Ltd.
COUR5.37-0.01
-0.19%
Coursera
META595.19-10.91
-1.80%
Meta Platforms
ZNTL4.33-0.12
-2.70%
Zentalis Pharmaceuticals
CORZ22.75-1.21
-5.05%
Core Scientific